National Patient Safety Board Act of 2026
- Sponsor
- Rep. Barragán, Nanette Diaz [D-CA-44]
- Committees
- Veterans' Affairs Committee (primary)
- Last action
- Oct 15, 2026
Bottom line
The bill creates a new federal board, modeled after transportation safety boards, to proactively address patient safety issues through systemic analysis and non-punitive recommendations.
What it actually does
This bill establishes an independent National Patient Safety Board (NPSB) within the Office of the Secretary of Health and Human Services. Its core mission is to prevent and reduce patient safety events by monitoring, studying causes, and formulating recommendations. The Board would include divisions for research, data collection, and in-depth studies, and would operate under nonpunitive restrictions to encourage reporting and learning.
Proponents argue
Proponents argue that a dedicated, independent board is crucial to systematically address the pervasive issue of preventable medical errors and patient harm, which currently lacks a centralized, proactive, and non-punitive approach. They would highlight the success of similar boards in other high-risk industries, such as the NTSB, in improving safety outcomes by focusing on systemic failures rather than individual blame.
Opponents contend
Opponents might raise concerns about creating another layer of bureaucracy within the federal health apparatus, potential overlap with existing agencies like AHRQ and CDC, and the significant costs associated with establishing and maintaining such a board. They might also question the effectiveness of a non-punitive approach in driving accountability for serious errors.
The bill is relatively short and clearly structured, making it accessible for an informed reader to understand its core provisions within a reasonable timeframe.
Section 2(a)
Establishment of the National Patient Safety Board
This provision formally establishes the National Patient Safety Board (NPSB) as an independent entity within the Office of the Secretary of Health and Human Services. The Board's primary purpose is to prevent and reduce patient safety events, aiming to create a centralized federal authority focused solely on systemic safety improvements in healthcare.
Supporters argue
Supporters argue that an independent board is essential to provide focused, non-biased oversight and recommendations for patient safety, free from the political pressures or competing priorities that might affect existing agencies.
Critics contend
Critics might argue that establishing a new independent board could lead to bureaucratic redundancy and turf wars with existing agencies already working on patient safety, potentially hindering rather than helping overall safety efforts.
Tradeoffs
The tension lies between the desire for independent, focused patient safety efforts and the potential for creating another layer of bureaucracy that might overlap with or duplicate existing federal health agency functions.
Section 2(b)
Core Duties and Authority of the NPSB
This section outlines the Board's core duties, including monitoring patient safety events, studying their context and causes, and formulating prevention recommendations. It grants the Board sole authority to approve patient safety measures, review reports from its divisions, require further studies or revisions, and make these reports publicly available within one year. The Board is also mandated to undergo annual audits and submit annual reports to Congress.
Section 2(d)
Board Membership and Expertise Requirements
The Board will consist of 5 members appointed by the President for 5-year staggered terms. Specific qualifications are mandated: at least 3 members must have expertise in patient safety or demonstrated experience in increasing safety in complex, high-risk industries, and at least 2 members must represent individuals who have experienced a patient safety event or have a family member who did. All members must adhere to conflict of interest policies.
Section 2(g)
Patient Safety Research and Data Collection
This section establishes the Patient Safety Research and Development Division. It mandates the creation of a public-private 'Health Care Safety Team' to recommend patient safety measures. Crucially, it requires the Director of this Division to obtain longitudinal, real-time, de-identified patient-level data from HHS and VA, establish a 'Patient Safety Reporting System' for public event reporting (anonymous or not), and create a 'data access portal' for public and private entities to voluntarily share data. The Division will aggregate and analyze this data, including by demographic factors, to identify disparities and prompt studies by the Study Division.
Section 2(h)
In-Depth Patient Safety Event Studies
This section establishes the Study Division, which conducts or supports in-depth studies of patient safety events. These studies are prompted by findings from the Research and Development Division, such as abnormal patterns, persistent harm, or identified disparities. Studies involve multidisciplinary expert teams, including human factors experts, and require permission to access facilities and communicate with staff. The division can also establish special boards of inquiry for novel infections and emerging pandemics to provide independent recommendations for national preparedness and response plans.
Section 2(j)
Protections Against Punitive Use of Board Information
This critical section stipulates that Board reports or publications are not admissible as evidence of individual or organizational liability in a civil action for damages, with an important caveat that this inadmissibility does not apply to data collected or housed outside the Board. It clarifies that Board information can inform standards of care but explicitly prohibits the Department of Health and Human Services from using Board data, reports, or work product to impose disciplinary or other punitive measures with respect to a healthcare provider. The Board also lacks authority to determine the rights or liabilities of any person.
The Director of the Patient Safety Research and Development Division must maintain and use data collected through the data access portal consistent with various privacy and confidentiality laws and frameworks, including the Federal Information Security Management Act of 2002 (FISMA), the 'Risk Management Framework' and 'Artificial Intelligence Risk Management Framework' issued by the National Institute of Standards and Technology (NIST), HIPAA privacy and security law, and the White House's 'Blueprint for an AI Bill of Rights.'
Section 2(g)(4)
Why it matters:This level of detail is typical for legislative language concerning data security and privacy, ensuring compliance with existing federal mandates and emerging policy guidance. It's standard legislative practice to reference these frameworks rather than detailing them in full.
Case for: Supporters would argue that explicitly referencing these robust privacy and security frameworks ensures that the vast amount of sensitive patient data collected by the Board is handled with the highest standards of protection, building public trust and mitigating risks of misuse.
Case against: Critics might argue that while important, the sheer number and complexity of referenced frameworks could create significant compliance burdens for the Board and participating entities, potentially slowing down data integration and analysis efforts due to stringent requirements.
Estimated impact: Ensures stringent data protection for potentially millions of patient records, influencing the Board's operational costs and data sharing agreements, and setting a high bar for data governance.
The Director of the Patient Safety Event Research and Development Division shall analyze patient-level data by race, ethnicity, gender, facility, age, social factors, and location to identify disparities in patient safety events.
Section 2(g)(5)(B)
Why it matters:This is a key analytical requirement within a broader set of data analysis duties. It's a significant detail but not the primary headline of the division's overall function, making it a specific instruction rather than a top-level duty.
Case for: Proponents would highlight this as a crucial equity-focused provision, ensuring that the Board actively works to uncover and address systemic biases and disparities in patient safety outcomes that might disproportionately affect certain demographic groups, leading to more equitable care.
Case against: Some might argue that collecting and analyzing data by these specific demographic categories could be complex and resource-intensive, and that the primary focus should remain on overall safety improvements rather than potentially divisive subgroup analysis, or that such analysis could be misinterpreted.
Estimated impact: Could lead to targeted interventions and policy changes to reduce health inequities, influencing healthcare delivery for vulnerable populations and potentially reshaping public health strategies.